Literature DB >> 19846946

Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin.

Tze-Chen Hsieh1, Joseph M Wu.   

Abstract

Prostate cancer (CaP) is a significant cause of death in American men. While men residing in Asia show a lower incidence of hormone-refractory prostate cancer (HRPC) compared to Caucasian males, Asian men who move to and live in the United States and adopt a western lifestyle have HRPC rates indistinguishable from Caucasian males. These findings suggest that Asian diets contain ingredients that might protect against the development of HRPC. The identity and mechanisms of such HRPC protective agents remain to be elucidated. An Asian diet may confer protection against HRPC owing to functional synergy between bioactive dietary agents, thus broadening the chemopreventive index, with increased distinct anticancer properties and decreased untoward effects. Here, whether or not a combination of epigallocatechin gallate (EGCG), genistein and quercetin, phytochemicals present in a traditional Asian diet, might exert synergy in controlling proliferation and gene expression was investigated in CWR22Rv1 CaP cells, an in vitro model mimicking CaP transition from AD (androgen dependence) to HRPC. Cell proliferation was inhibited approximately 40%, approximately 15% and approximately 20%, respectively by 2.5 microM EGCG, genistein and quercetin used alone. The co-administration of 2.5 microM of these phytochemicals suppressed proliferation synergistically in the CWR22Rv1 cells maintained in RPMI-1640 supplemented with 10% fetal bovine serum, but not in the cells maintained as serum-free cultures. Synergy in the expression of androgen receptor, tumor suppressor p53 and detoxification enzyme quinone reductase type 1, denoted NQO1, was also observed for the combined phytochemicals. These results demonstrate the feasibility of developing a diet-based combinatorial approach for CaP prevention and treatment and raise the possibility that serum added to culture medium might affect uptake, bioavailability and biological efficacy of dietary phytochemicals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846946      PMCID: PMC3641843     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  47 in total

Review 1.  Potential synergy of phytochemicals in cancer prevention: mechanism of action.

Authors:  Rui Hai Liu
Journal:  J Nutr       Date:  2004-12       Impact factor: 4.798

2.  Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials.

Authors:  T C Hsieh; P Burfeind; K Laud; J M Backer; F Traganos; Z Darzynkiewicz; J M Wu
Journal:  Int J Oncol       Date:  1999-08       Impact factor: 5.650

Review 3.  Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.

Authors:  R Agarwal
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

4.  Quantitative combination effects between sulforaphane and 3,3'-diindolylmethane on proliferation of human colon cancer cells in vitro.

Authors:  Gerlinde Pappa; Julia Strathmann; Maria Löwinger; Helmut Bartsch; Clarissa Gerhäuser
Journal:  Carcinogenesis       Date:  2007-02-28       Impact factor: 4.944

5.  Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines.

Authors:  Marcus V Cronauer; Wolfgang A Schulz; Tatjana Burchardt; Rolf Ackermann; Martin Burchardt
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

6.  Beta-carotene: a cancer chemopreventive agent or a co-carcinogen?

Authors:  Moreno Paolini; Sherif Z Abdel-Rahman; Andrea Sapone; Gian Franco Pedulli; Paolo Perocco; Giorgio Cantelli-Forti; Marvin S Legator
Journal:  Mutat Res       Date:  2003-06       Impact factor: 2.433

7.  Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.

Authors:  Jungil Hong; Hong Lu; Xiaofeng Meng; Jae-Ha Ryu; Yukihiko Hara; Chung S Yang
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

8.  Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.

Authors:  Leslie Fischer; Chrysa Mahoney; A Robert Jeffcoat; Matthew A Koch; Brian E Thomas; John L Valentine; Thomas Stinchcombe; Jarol Boan; James A Crowell; Steven H Zeisel
Journal:  Nutr Cancer       Date:  2004       Impact factor: 2.900

9.  International trends in prostate-cancer mortality: the decrease is continuing and spreading.

Authors:  P D Baade; M D Coory; J F Aitken
Journal:  Cancer Causes Control       Date:  2004-04       Impact factor: 2.506

10.  Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity.

Authors:  Andrew J Coldman; Norman Phillips; Thomas A Pickles
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

View more
  26 in total

1.  Effect of Combined Treatment with Ursolic Acid and Resveratrol on Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate.

Authors:  Jiyoon Cho; Okkyung Rho; Jacob Junco; Steve Carbajal; Dionicio Siegel; Thomas J Slaga; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-22

2.  Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells.

Authors:  Noriyuki Nishimura; Tri Budi Hartomo; Thi Van Huyen Pham; Myeong Jin Lee; Tomoto Yamamoto; Satoru Morikawa; Daiichiro Hasegawa; Hiroki Takeda; Keiichiro Kawasaki; Yoshiyuki Kosaka; Nobuyuki Yamamoto; Ikuko Kubokawa; Takeshi Mori; Tomoko Yanai; Akira Hayakawa; Yasuhiro Takeshima; Kazumoto Iijima; Masafumi Matsuo; Hisahide Nishio
Journal:  Environ Health Prev Med       Date:  2011-09-10       Impact factor: 3.674

Review 3.  Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Tatsuro Watanabe; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-28       Impact factor: 4.553

Review 4.  Green tea polyphenols as proteasome inhibitors: implication in chemoprevention.

Authors:  H Yang; K Landis-Piwowar; T H Chan; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

5.  Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.

Authors:  Wei He; Li-Xia Li; Qing-Jiao Liao; Chun-Lan Liu; Xu-Lin Chen
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

6.  Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells.

Authors:  Ramakumar Tummala; Wei Lou; Allen C Gao; Nagalakshmi Nadiminty
Journal:  Mol Cancer Ther       Date:  2017-07-20       Impact factor: 6.261

7.  Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1.

Authors:  Kewei Zhu; Wanchun Wang
Journal:  Tumour Biol       Date:  2015-10-24

8.  The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.

Authors:  Su-Ni Tang; Chandan Singh; Dara Nall; Daniel Meeker; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Mol Signal       Date:  2010-08-18

Review 9.  Molecular mechanisms of action of quercetin in cancer: recent advances.

Authors:  Dharambir Kashyap; Sonam Mittal; Katrin Sak; Paavan Singhal; Hardeep Singh Tuli
Journal:  Tumour Biol       Date:  2016-07-22

Review 10.  Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability.

Authors:  Hu Wang; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Jong-Hun Lee; Ah-Ng Tony Kong
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.